3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Phase 2
1
Status
Unknown
2
Completed
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Conditions
Vomiting
4
Postoperative Nausea and Vomiting
2
Neoplasms
2
Ovarian Neoplasms
1
Nausea
1
Myofibroma
1
Hematologic Neoplasms
1
Adenomyosis
1
Interventions
Exercise
19
Drug Therapy
18
pembrolizumab
13
Capecitabine
11
Blood Specimen Collection
11
Surveys and Questionnaires
10
Radiotherapy
10
Paclitaxel
9
Dexamethasone
9
Nivolumab
8
Standard of Care
7
Oxaliplatin
7
Fluorouracil
7
Erlotinib Hydrochloride
7
apatinib
6
Interviews as Topic
6
Gemcitabine
6
Control Groups
6
Cisplatin
6
Therapeutics
5
Neoadjuvant Therapy
5
Mindfulness-Based Cognitive Therapy
5
Metformin
5
Injections
5
Everolimus
5
Docetaxel
5
Cyclophosphamide
5
Bevacizumab
5
sintilimab
4
atezolizumab
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Unknown
×
Neoplasms
×
ramosetron
×
Clear all
NCT01536691
2012-10-03
ROAD
Hallym University Medical Center
Phase 3
Unknown
338 enrolled
NCT01046461
2012-02-17
RAD
Hallym University Medical Center
Phase 2
Unknown
41 enrolled